IDH have announced that they can enter the US market with their Direct Renin assay.
This is used to find the amount of active renin present in the blood. Results of the test are used to assist clinicians in the investigation of hypertension related disorders such as primary aldosteronism and renovascular hypertension. This is a fast and reliable alternative to existing manual methods, and a necessity when screening in extended hypertensive populations.
Hypertension is the third leading cause of death after malnutrition and diseases related to smoking. One in every three American adults have high blood pressure.
IDS first launched the automated Direct Renin immunoassay in Europe in June 2012.